HIV-1-derived self-inactivating lentivirus vector induces megakaryocyte lineage-specific gene expression

被引:8
|
作者
Yasui, K
Furuta, RA
Matsumoto, K
Tani, Y
Fujisawa, J
机构
[1] Kansai Med Univ, Dept Microbiol, Moriguchi, Osaka 5708506, Japan
[2] Osaka Red Cross Blood Ctr, Osaka, Japan
关键词
gene therapy; lentiviral vector; GP2b promoter; megakaryocyte-specific expression; peripheral blood CD34(+) cell;
D O I
10.1016/j.micinf.2004.11.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pluripotent, self-renewing, hematopoietic stem cells are considered good targets for gene modification to treat a wide variety of disorders. However, as many genes are expressed in a stage-specific manner during the course of hematopoietic development, it is necessary to establish a lineage-specific gene expression system to ensure the proper expression of transduced genes in hematopoietic stem cells. In this study, we constructed a VSV-G-pseudotyped, human immunodeficiency virus type I-based, self-inactivating lentivirus vector that expressed green fluorescent protein (GFP) under the control of the human CD41 (glycoprotein 2b; GP2b) promoter; this activity is restricted to megoakaryocytic lineage cells. The recombinant virus was used to infect human peripheral blood CD34(+) (hematopoietic stem/progenitor) cells, and lineage-specific gene expression was monitored with GFP measurements. The analysis by FACS determined that GFP expression driven by the GP2b promoter was restricted to megakaryocytic progenitors and was not present in erythrocytes. Furthermore, in the hematopoietic colony-forming assay, GFP expression was restricted to colony-forming units-megakaryocyte (CFU-Meg) colonies under the control of the GP2b promoter, whereas all myeloid colonies (burst-forming units-erythroid, colony-forming units-granulocyte-macrophage, and CFU-Meg) expressed GFP when the transgene was regulated by the cytomegalovirus promoter. These results demonstrated lineage-specific expression after gene transduction of hematopoietic stem cells. The application of this vector system should provide a useful tool for gene therapy to treat disorders associated with megakaryocyte (platelet) dysfunction. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [1] Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
    Zufferey, R
    Dull, T
    Mandel, RJ
    Bukovsky, A
    Quiroz, D
    Naldini, L
    Trono, D
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 9873 - 9880
  • [2] A HIV-2-based self-inactivating vector for enhanced gene transduction
    Mukherjee, Sayandip
    Lee, Hui-Ling Rose
    Pacchia, Annmarie L.
    Ron, Yacov
    Dougherty, Joseph P.
    JOURNAL OF BIOTECHNOLOGY, 2007, 127 (04) : 745 - 757
  • [3] HIV-1-derived lentivirus vector-based antisense gene therapy: Towards an alternative treatment for HIV/AIDS
    Dropulic, B
    Humeau, L
    Binder, GK
    Lu, XB
    Slepushkin, V
    Merling, R
    Echeagaray, P
    Pereira, M
    Slepushkina, T
    Barnett, S
    Dropulic, LK
    Carroll, R
    Levine, B
    MacGregor, RR
    Junes, CH
    MOLECULAR THERAPY, 2004, 9 : S384 - S384
  • [4] Pattern of activity of viral and housekeeping gene using self-inactivating lentivirus vector delivery into the mouse retina
    Kostic, C
    Chiodini, F
    Hornfeld, D
    Tekaya, M
    Salmon, P
    Déglon, N
    Aebischer, P
    Munier, F
    Arsenijevic, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1309 - U1309
  • [5] Long-term transduction and lineage-specific expression of self-inactivating (SIN) lentiviral vectors in murine hematopoietic stem cells.
    Moreau-Gaudry, F
    Azim, M
    Jiang, G
    Xia, P
    Perelman, N
    Meyerrose, T
    Nolta, J
    Malik, P
    BLOOD, 2000, 96 (11) : 590A - +
  • [6] Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
    Richard, E
    Mendez, M
    Mazurier, F
    Morel, C
    Costet, P
    Xia, P
    Fontanellas, A
    Geronimi, F
    Cario-André, M
    Taine, L
    Ged, C
    Malik, P
    de Verneuil, H
    Moreau-Gaudry, F
    MOLECULAR THERAPY, 2001, 4 (04) : 331 - 338
  • [7] Promoters as a tool to target gene expression into the mouse retina using subretinal injection of self-inactivating lentiviral vector
    Kostic, C
    Jaquet, M
    Salmon, P
    Deglon, N
    Aebischer, P
    Schorderet, DF
    Munier, FL
    Arsenijevic, Y
    MOLECULAR THERAPY, 2003, 7 (05) : S139 - S140
  • [8] Promoter interference mediated by the U3 region of HIV-1-derived lentivirus vectors: Effects on transgene expression
    Ginn, SL
    Fleming, J
    Rowe, PB
    Alexander, IE
    JOURNAL OF GENE MEDICINE, 2003, 5 (05): : S6 - S6
  • [9] Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
    Pike-Overzet, K.
    Rodijk, M.
    Ng, Y-Y
    Baert, M. R. M.
    Lagresle-Peyrou, C.
    Schambach, A.
    Zhang, F.
    Hoeben, R. C.
    Hacein-Bey-Abina, S.
    Lankester, A. C.
    Bredius, R. G. M.
    Driessen, G. J. A.
    Thrasher, A. J.
    Baum, C.
    Cavazzana-Calvo, M.
    van Dongen, J. J. M.
    Staal, F. J. T.
    LEUKEMIA, 2011, 25 (09) : 1471 - 1483
  • [10] In vivo liver-directed gene expression by a conditional self-inactivating (C-SIN) retroviral vector.
    Hwang, JJ
    Liu, PX
    Kaiser, S
    Anderson, F
    HEPATOLOGY, 1998, 28 (04) : 504A - 504A